![Amy Parison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Parison
Director of Finance/CFO at
EDITAS MEDICINE, INC.
Net worth: 48 503 $ as of 30/06/2026
Profile
Amy Parison is currently Chief Financial Officer & Senior Vice President at Editas Medicine, Inc. since 2025.
Formerly, Ms. Parison was Corporate Controller at Rubius Therapeutics, Inc. from 2021 to 2022.
Education includes undergraduate and graduate degrees from Babson College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2026 | 14,970 ( 0.01% ) | 48 503 $ | 30/06/2026 |
Amy Parison active positions
| Companies | Position | Start |
|---|---|---|
| EDITAS MEDICINE, INC. | Director of Finance/CFO | 28/03/2025 |
Former positions of Amy Parison
| Companies | Position | End |
|---|---|---|
| RUBIUS THERAPEUTICS | Chief Operating Officer | 01/08/2021 |
Training of Amy Parison
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Amy Parison
